We determined that the 18F-Z HER2-Affibody radiotracer used in PET imaging, when combined with corresponding MR images, provided the most suitable platform for robust and accurate volume quantification of HER2-positive breast cancer lesions in small-animal models. The gene discussed is ERBB2; the disease is breast carcinoma.